LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Inicio・Lista de Acciones・Compugen Ltd

Compugen Ltd

Abierto

1.94 -1.52

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.9

Máximo

1.97

Métricas clave
By Trading Economics
Ingresos	2.6M -7.3M
Ventas	-31M 2.6M
BPA	-0.08
Margen de beneficio	-283.978
EBITDA	-8.5M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+103.05 upside

Dividendos
By Dow Jones
Próximas Ganancias	5 nov 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	47M 640M
Apertura anterior	3.46
Cierre anterior	1.94

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

1.96 / 2.01 Soporte y Resistencia

Compugen Ltd Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

19 dic 2023, 12:14 UTC

Adquisiciones, fusiones, absorciones

Compugen Stock Rockets On Anti-Tumor Drug Deal With Gilead -- MarketWatch

Comparación entre iguales

Cambio de precio

Compugen Ltd Esperado

Precio Objetivo

By TipRanks

103.05% repunte

Estimación a 12 meses

Media 4 USD 103.05%

Máximo 4 USD

Mínimo 4 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Compugen Ltd Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

1.96 / 2.01Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Bullish events outweigh bearish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

EBITDA

Beneficio operativo

Acerca de Compugen Ltd

Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.